Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Ovarian Neoplasms

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 85 articles: HTML format Text format

Single Articles

February 2010
1. IORIO E , Ricci A, Bagnoli M, Pisanu ME, et al
   Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. YAN X , Yin J, Yao H, Mao N, et al
   Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. GALANIS E , Hartmann LC, Cliby WA, Long HJ, et al
   Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer.
   Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
4. HONG H , Yen HY, Brockmeyer A, Liu Y, et al
   Changes in the Mouse Estrus Cycle in Response to Brca1 Inactivation Suggest a Potential Link between Risk Factors for Familial and Sporadic Ovarian Cancer.
   Cancer Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. KOBEL M , Gilks CB, Huntsman DG
   Adult-type granulosa cell tumors and FOXL2 mutation.
   Cancer Res. 2009;69:9160-2.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SINGH P , Alley TL, Wright SM, Kamdar S, et al
   Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes.
   Cancer Res. 2009;69:9422-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. MORAN-JONES K , Grindlay J, Jones M, Smith R, et al
   hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration.
   Cancer Res. 2009;69:9219-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. HERRERA B , van Dinther M, Ten Dijke P, Inman GJ, et al
   Autocrine Bone Morphogenetic Protein-9 Signals through Activin Receptor-like Kinase-2/Smad1/Smad4 to Promote Ovarian Cancer Cell Proliferation.
   Cancer Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. CAO Y , Marks JD, Marks JW, Cheung LH, et al
   Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
   Cancer Res. 2009;69:8987-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. KUSUMBE AP , Bapat SA
    Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor Dormancy.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SHAO M , Cao L, Shen C, Satpathy M, et al
    Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
12. SAPOZNIK S , Cohen B, Tzuman Y, Meir G, et al
    Gonadotropin-Regulated Lymphangiogenesis in Ovarian Cancer Is Mediated by LEDGF-Induced Expression of VEGF-C.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CHEN YF , Chou CY, Wilkins RJ, Ellory JC, et al
    Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion.
    Cancer Res. 2009;69:8585-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ARAFA ES , Zhu Q, Barakat BM, Wani G, et al
    Tangeretin Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Downregulation of Phosphoinositide 3-Kinase/Akt Signaling Pathway.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BHATTACHARYA R , Nicoloso M, Arvizo R, Wang E, et al
    MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. HUANG YW , Liu JC, Deatherage DE, Luo J, et al
    Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
17. REIM F , Dombrowski Y, Ritter C, Buttmann M, et al
    Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells.
    Cancer Res. 2009;69:8058-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
18. SCARLETT UK , Cubillos-Ruiz JR, Nesbeth YC, Martinez DG, et al
    In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LEE MH , Choi BY, Kundu JK, Shin YK, et al
    Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. MOSS NM , Barbolina MV, Liu Y, Sun L, et al
    Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. SAKAI W , Swisher EM, Jacquemont C, Chandramohan KV, et al
    Functional Restoration of BRCA2 Protein by Secondary BRCA2 Mutations in BRCA2-Mutated Ovarian Carcinoma.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. HUANG YH , Zugates GT, Peng W, Holtz D, et al
    Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice.
    Cancer Res. 2009;69:6184-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. NESBETH Y , Scarlett U, Cubillos-Ruiz J, Martinez D, et al
    CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion.
    Cancer Res. 2009;69:6331-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
24. MASAMHA CP , Benbrook DM
    Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. FISTER S , Gunthert AR, Aicher B, Paulini KW, et al
    GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ZHANG XY , Chen J, Zheng YF, Gao XL, et al
    Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. REBBECK TR , Mitra N, Domchek SM, Wan F, et al
    Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. MIGALOVICH HS , Kalchenko V, Nevo N, Meir G, et al
    Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media.
    Cancer Res. 2009;69:5610-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
29. QIAN F , Villella J, Wallace PK, Mhawech-Fauceglia P, et al
    Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. STRAUSS R , Sova P, Liu Y, Li ZY, et al
    Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. LIU P , Khurana A, Rattan R, He X, et al
    Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
    Cancer Res. 2009;69:4843-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
32. GOURLEY C , Paige AJ, Taylor KJ, Ward C, et al
    WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin {alpha}3.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. DIFEO A , Huang F, Sangodkar J, Terzo EA, et al
    KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. GHOUL A , Serova M, Astorgues-Xerri L, Bieche I, et al
    Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. DONG X , Mattingly CA, Tseng MT, Cho MJ, et al
    Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Cancer Res. 2009;69:3918-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
36. KUO KT , Guan B, Feng Y, Mao TL, et al
    Analysis of DNA Copy Number Alterations in Ovarian Serous Tumors Identifies New Molecular Genetic Changes in Low-Grade and High-Grade Carcinomas.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
37. ECKSTEIN N , Servan K, Hildebrandt B, Politz A, et al
    Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CAO F , Li Z, Lee A, Liu Z, et al
    Noninvasive De novo Imaging of Human Embryonic Stem Cell-Derived Teratoma Formation.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SCHILDKRAUT JM , Goode EL, Clyde MA, Iversen ES, et al
    Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
40. TWOROGER SS , Gate MA, Lee IM, Buring JE, et al
    Polymorphisms in the Vitamin D Receptor and Risk of Ovarian Cancer in Four Studies.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SLACK-DAVIS JK , Atkins KA, Harrer C, Hershey ED, et al
    Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. STOLZENBERG-SOLOMON RZ , Hayes RB, Horst RL, Anderson KE, et al
    Serum Vitamin D and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Screening Trial.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. CHOI JH , Sheu JJ, Guan B, Jinawath N, et al
    Functional Analysis of 11q13.5 Amplicon Identifies Rsf-1 (HBXAP) as a Gene Involved in Paclitaxel Resistance in Ovarian Cancer.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. CHAUHAN SC , Vannatta K, Ebeling MC, Vinayek N, et al
    Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer.
    Cancer Res. 2009;69:765-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
45. FACA VM , Hanash SM
    In-Depth Proteomics to Define the Cell Surface and Secretome of Ovarian Cancer Cells and Processes of Protein Shedding.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. JIN C , Yang YA, Anver MR, Morris N, et al
    Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness.
    Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
47. YANG N , Kaur S, Volinia S, Greshock J, et al
    MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
    Cancer Res. 2008;68:10307-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MOZZETTI S , Iantomasi R, De Maria I, Prislei S, et al
    Molecular mechanisms of patupilone resistance.
    Cancer Res. 2008;68:10197-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. ASHWORTH A
    Drug resistance caused by reversion mutation.
    Cancer Res. 2008;68:10021-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SAWICKI JA
    Fetal microchimerism and cancer.
    Cancer Res. 2008;68:9567-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
51. BARTHOLOMEUSZ C , Rosen D, Wei C, Kazansky A, et al
    PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival.
    Cancer Res. 2008;68:9302-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. RAYHMAN O , Klipper E, Muller L, Davidson B, et al
    Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells.
    Cancer Res. 2008;68:9265-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. PARK JT , Shih IeM, Wang TL
    Identification of pbx1, a potential oncogene, as a notch3 target gene in ovarian cancer.
    Cancer Res. 2008;68:8852-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. SONG H , Koessler T, Ahmed S, Ramus SJ, et al
    Association Study of Prostate Cancer Susceptibility Variants with Risks of Invasive Ovarian, Breast, and Colorectal Cancer.
    Cancer Res. 2008;68:8837-8842.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
55. GUERRA E , Trerotola M, Dell' Arciprete R, Bonasera V, et al
    A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.
    Cancer Res. 2008;68:8113-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
56. LEE YS , Lim KH, Guo X, Kawaguchi Y, et al
    The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.
    Cancer Res. 2008;68:7561-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HUARTE E , Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, et al
    Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity.
    Cancer Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
58. SPADARO F , Ramoni C, Mezzanzanica D, Miotti S, et al
    Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
    Cancer Res. 2008;68:6541-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. PON YL , Zhou HY, Cheung AN, Ngan HY, et al
    p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Cancer Res. 2008;68:6524-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. PALMA MD , Domchek SM, Stopfer J, Erlichman J, et al
    The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families.
    Cancer Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
61. APONTE M , Jiang W, Lakkis M, Li MJ, et al
    Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
    Cancer Res. 2008;68:5839-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. MOSERLE L , Indraccolo S, Ghisi M, Frasson C, et al
    The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.
    Cancer Res. 2008;68:5658-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. HWANG JY , Mangala LS, Fok JY, Lin YG, et al
    Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
    Cancer Res. 2008;68:5849-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. CHOI JH , Park JT, Davidson B, Morin PJ, et al
    Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.
    Cancer Res. 2008;68:5716-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BONOME T , Levine DA, Shih J, Randonovich M, et al
    A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
    Cancer Res. 2008;68:5478-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. KIKUCHI R , Tsuda H, Kozaki K, Kanai Y, et al
    Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Cancer Res. 2008;68:5067-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. ENGELS K , Knauer SK, Loibl S, Fetz V, et al
    NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
    Cancer Res. 2008;68:5159-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
68. ABEDINI MR , Muller EJ, Brun J, Bergeron R, et al
    Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
    Cancer Res. 2008;68:4511-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. DIMPLE C , Nair SS, Rajhans R, Pitcheswara PR, et al
    Role of PELP1/MNAR signaling in ovarian tumorigenesis.
    Cancer Res. 2008;68:4902-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. COWDEN DAHL KD , Symowicz J, Ning Y, Gutierrez E, et al
    Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
    Cancer Res. 2008;68:4606-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. ZHANG S , Balch C, Chan MW, Lai HC, et al
    Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
    Cancer Res. 2008;68:4311-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. SHEU JJ , Choi JH, Yildiz I, Tsai FJ, et al
    The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1.
    Cancer Res. 2008;68:4050-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
73. BASU A , Adkins B, Basu C
    Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway.
    Cancer Res. 2008;68:2795-802.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. SWISHER EM , Sakai W, Karlan BY, Wurz K, et al
    Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.
    Cancer Res. 2008;68:2581-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. KELEMEN LE , Sellers TA, Schildkraut JM, Cunningham JM, et al
    Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
    Cancer Res. 2008;68:2498-506.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. SAWADA K , Mitra AK, Radjabi AR, Bhaskar V, et al
    Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
    Cancer Res. 2008;68:2329-39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LOTAN T , Hickson J, Souris J, Huo D, et al
    c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Cancer Res. 2008;68:2166-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
78. JEON BH , Jang C, Han J, Kataru RP, et al
    Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Cancer Res. 2008;68:1100-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. ZECCHINI S , Bianchi M, Colombo N, Fasani R, et al
    The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
    Cancer Res. 2008;68:1110-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. KLINCK R , Bramard A, Inkel L, Dufresne-Martin G, et al
    Multiple alternative splicing markers for ovarian cancer.
    Cancer Res. 2008;68:657-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
82. YANG H , Kong W, He L, Zhao JJ, et al
    MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Cancer Res. 2008;68:425-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
84. LI L , Ryser S, Dizin E, Pils D, et al
    Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Cancer Res. 2007;67:11876-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. GAITHER A , Porter D, Yao Y, Borawski J, et al
    A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.
    Cancer Res. 2007;67:11493-8.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: